Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$54.87

-2.94 (-5.09%)

13:45
01/08/18
01/08
13:45
01/08/18
13:45

Sarepta sees 2018 Exondys 51 revenue $295M-$305M

The consensus estimate for total company revenue is $301.39M. The company said, "In 2017, we set the stage by successfully launching our first therapy, entering into important collaborations and ensuring we have ample resources to invest in our impressive pipeline. In 2018, we are accelerating our plans, moving 16 programs through various stages of development, and planning for multiple milestones and inflection points. And we are doing all of this to serve our lofty but achievable aspiration: to improve and extend the lives of the thousands of children suffering from DMD, expand our platform to other rare diseases, and in so doing, to become one of the most important global leaders in precision genetic medicine to reduce human suffering and treat disease."

  • 08

    Jan

SRPT Sarepta
$54.87

-2.94 (-5.09%)

12/18/17
MSCO
12/18/17
NO CHANGE
MSCO
Morgan Stanley sees opportunities in biotech amid 'limited' investor conviction
With clinical catalysts in large-cap Biotechnology limited to only five key Phase III readouts - three of which are from Alexion (ALXN) - investors are describing their 2018 picks in the space as the "least worst" of the group, according to Morgan Stanley analyst Matthew Harrison. However, he believes this lack of conviction creates real opportunity for outsized moves in 2018, with Amgen (AMGN) identified by Harrison as the biggest potential beneficiary of M&A given "its likely newfound access" to about $39B in offshore cash. Other biotech names the analyst highlights on the up side include Biogen (BIIB), BioMarin (BMRN), Biohaven (BHVN) and Sarepta (SRPT). Meanwhile, Harrison highlights his concerns about potential downside for BioVerativ (BIVV) and Innoviva (INVA), on both of which he keeps Underweight ratings.
12/27/17
OPCO
12/27/17
NO CHANGE
Target $76
OPCO
Outperform
Oppenheimer bullish on Sarepta into 2018
Oppenheimer analyst Hartaj Singh highlights Sarepta as a key SMID-cap pick in his coverage universe. The analyst believes Sarepta enters 2018 firing on all commercial and clinical cylinders with new CEO D. Ingram bringing a strategic and tactical focus to the company. While competitive intensity in Duchenne muscular dystrophy is starting to build, Singh thinks the competitive landscape is still a mish-mash of approaches, most of which are still in early/mid-stage development. He does not see any meaningful competition to Sarepta's DMD franchise for another 3-5 years. The analyst reiterates an Outperform rating and $76 price target on the shares.
01/03/18
JANY
01/03/18
INITIATION
Target $75
JANY
Buy
Sarepta initiated with a Buy at Janney Capital
Janney analyst Yun Zhong initiated Sarepta with a Buy rating and a $75 price target.
01/04/18
RHCO
01/04/18
INITIATION
Target $24
RHCO
Buy
Summit Therapeutics initiated with a Buy at SunTrust
SunTrust analyst Edward Nash initiated Summit Therapeutics (SMMT) with a Buy rating and a price target of $24. Nash says the company's ezutromid drug has the potential to address all 50K cases of Duchenne muscular dystrophy in the developed world, expecting the key interim data announced this quarter to be strong. The analyst notes that DMD remains a "high profile orphan disease", and only Sarepta's (SRPT) Exondys 51 treatment address about 13% of its patients.

TODAY'S FREE FLY STORIES

ONCE

Spark Therapeutics

$73.03

-3.69 (-4.81%)

, PFE

Pfizer

$35.79

0.15 (0.42%)

05:44
05/22/18
05/22
05:44
05/22/18
05:44
Hot Stocks
Spark Therapeutics, Pfizer announce data SPK-9001 ongoing Phase 1/2 trial »

Spark Therapeutics (ONCE)…

ONCE

Spark Therapeutics

$73.03

-3.69 (-4.81%)

PFE

Pfizer

$35.79

0.15 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

FMC

FMC Corporation

$91.30

-0.22 (-0.24%)

05:41
05/22/18
05/22
05:41
05/22/18
05:41
Hot Stocks
FMC Corporation awarded contract for two fertilizer plants in India »

TechnipFMC, in consortium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$5.17

0.05 (0.98%)

05:40
05/22/18
05/22
05:40
05/22/18
05:40
Hot Stocks
Sprint partners with Scopeworker on multi-billion dollar 5G depoloyment »

Scopeworker announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSHD

Goosehead Insurance

$16.19

0.12 (0.75%)

05:39
05/22/18
05/22
05:39
05/22/18
05:39
Initiation
Goosehead Insurance initiated  »

Goosehead Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMAR

Smartsheet

$20.00

0.14 (0.70%)

05:38
05/22/18
05/22
05:38
05/22/18
05:38
Initiation
Smartsheet initiated  »

Smartsheet initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

VLRS

Volaris

$5.42

-0.05 (-0.91%)

05:19
05/22/18
05/22
05:19
05/22/18
05:19
Recommendations
Volaris analyst commentary  »

Volaris price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BAX

Baxter

$72.08

1.4603 (2.07%)

05:16
05/22/18
05/22
05:16
05/22/18
05:16
Recommendations
Baxter analyst commentary  »

Baxter buybacks should…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOCU

DocuSign

$43.06

-1.73 (-3.86%)

05:08
05/22/18
05/22
05:08
05/22/18
05:08
Initiation
DocuSign initiated  »

DocuSign initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

AROC

Archrock

$12.30

0.35 (2.93%)

05:07
05/22/18
05/22
05:07
05/22/18
05:07
Recommendations
Archrock analyst commentary  »

Archrock added to Alpha…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTG

Pure Storage

$23.60

-0.065 (-0.27%)

05:05
05/22/18
05/22
05:05
05/22/18
05:05
Recommendations
Pure Storage analyst commentary  »

Pure Storage weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 07

    Jun

  • 12

    Jun

  • 10

    Jul

DOCU

DocuSign

$43.06

-1.73 (-3.86%)

05:02
05/22/18
05/22
05:02
05/22/18
05:02
Initiation
DocuSign initiated  »

DocuSign initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

SSL

Sasol

$37.93

0.05 (0.13%)

05:00
05/22/18
05/22
05:00
05/22/18
05:00
Downgrade
Sasol rating change  »

Sasol downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSHD

Goosehead Insurance

$16.19

0.12 (0.75%)

04:58
05/22/18
05/22
04:58
05/22/18
04:58
Initiation
Goosehead Insurance initiated  »

Goosehead Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EXTR

Extreme Networks

$9.16

-0.02 (-0.22%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Extreme Networks management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

  • 29

    May

ALG

Alamo Group

$100.36

1.34 (1.35%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Alamo Group management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

ALNA

Allena Pharmaceuticals

$15.99

-0.01 (-0.06%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Allena Pharmaceuticals management to meet with Wedbush »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

CTIC

CTI BioPharma

$4.79

-0.1 (-2.05%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
CTI BioPharma management to meet with Oppenheimer »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

EHTH

eHealth

$20.06

0.26 (1.31%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
eHealth management to meet with Craig Hallum »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 29

    May

BAYRY

Bayer

$0.00

(0.00%)

, BDX

Becton Dickinson

$228.74

3.73 (1.66%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
American Thoracic Society to hold a conference »

ATS 2018 will be held in…

BAYRY

Bayer

$0.00

(0.00%)

BDX

Becton Dickinson

$228.74

3.73 (1.66%)

BIIB

Biogen

$277.69

-2.66 (-0.95%)

BSX

Boston Scientific

$30.65

0.19 (0.62%)

CELG

Celgene

$74.69

-3.7 (-4.72%)

DNA

Bought by RHHBY

$0.00

(0.00%)

FGEN

FibroGen

$52.55

1.45 (2.84%)

GSK

GlaxoSmithKline

$40.05

0.005 (0.01%)

HRC

Hill-Rom

$90.70

0.12 (0.13%)

INNV

Innovus Pharmaceuticals

$0.00

(0.00%)

RETA

Reata Pharmaceuticals

$31.86

0.28 (0.89%)

OCX

OncoCyte

$2.50

-0.05 (-1.96%)

VVUS

VIVUS

$0.80

0.0079 (1.00%)

NBRV

Nabriva Therapeutics

$4.54

-0.89 (-16.39%)

MYL

Mylan

$39.55

-0.1 (-0.25%)

MASI

Masimo

$97.75

0.64 (0.66%)

TEVA

Teva

$21.09

-0.14 (-0.66%)

STEM

Ticker changed to MBOT

$0.00

(0.00%)

JAZZ

Jazz Pharmaceuticals

$166.01

-1.59 (-0.95%)

REGN

Regeneron

$296.58

-5.29 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 13

    Jun

  • 13

    Jun

  • 14

    Jun

  • 16

    Jun

  • 25

    Jun

  • 26

    Jun

  • 11

    Aug

  • 07

    Sep

  • 20

    Oct

  • 13

    Nov

  • 20

    Dec

SYF

Synchrony

$35.73

0.29 (0.82%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Synchrony management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 30

    May

PES

Pioneer Energy

$6.13

0.275 (4.70%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Pioneer Energy management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 23

    May

ATO

Atmos Energy

$85.25

0.37 (0.44%)

, AVA

Avista

$52.62

0.07 (0.13%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
Credit Suisse to hold meetings at AGA Financial Forum »

Credit Suisse Company…

ATO

Atmos Energy

$85.25

0.37 (0.44%)

AVA

Avista

$52.62

0.07 (0.13%)

BKH

Black Hills

$56.34

0.12 (0.21%)

CMS

CMS Energy

$43.96

-0.16 (-0.36%)

CNP

CenterPoint Energy

$25.21

-0.115 (-0.45%)

D

Dominion

$63.71

0.42 (0.66%)

DTE

DTE Energy

$99.96

0.04 (0.04%)

UK

Union Carbide

$0.00

(0.00%)

ED

Consolidated Edison

$73.82

-0.14 (-0.19%)

NI

NiSource

$24.39

-0.05 (-0.20%)

NJR

New Jersey Resources

$43.15

0.3 (0.70%)

NWE

NorthWestern

$53.48

0.26 (0.49%)

SO

Southern Company

$43.42

0.68 (1.59%)

SR

Spire

$70.08

0.4 (0.57%)

SRE

Sempra Energy

$102.64

0.65 (0.64%)

WEC

WEC Energy

$60.20

-0.3 (-0.50%)

XEL

Xcel Energy

$43.55

-0.15 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 25

    Jun

ALNY

Alnylam

$100.88

-2.12 (-2.06%)

, SNY

Sanofi

$38.78

-0.09 (-0.23%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
World Federation of Hemophilia to hold a conference »

2018 World Congress of…

ALNY

Alnylam

$100.88

-2.12 (-2.06%)

SNY

Sanofi

$38.78

-0.09 (-0.23%)

BMRN

BioMarin

$89.35

0.4 (0.45%)

BAYRY

Bayer

$0.00

(0.00%)

NVO

Novo Nordisk

$48.70

-0.02 (-0.04%)

PFE

Pfizer

$35.79

0.15 (0.42%)

SHPG

Shire

$169.00

-0.62 (-0.37%)

ONCE

Spark Therapeutics

$73.03

-3.69 (-4.81%)

QURE

uniQure

$31.44

0.08 (0.26%)

DNA

Bought by RHHBY

$0.00

(0.00%)

RHHBY

Roche

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 30

    May

  • 05

    Jun

  • 11

    Aug

  • 10

    Sep

  • 12

    Sep

  • 20

    Oct

  • 21

    Dec

  • 28

    Jan

SM

SM Energy

$27.18

0.52 (1.95%)

, APC

Anadarko

$71.69

1.12 (1.59%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
JPMorgan to hold a bus tour »

Denver Energy Bus Tour…

SM

SM Energy

$27.18

0.52 (1.95%)

APC

Anadarko

$71.69

1.12 (1.59%)

QEP

QEP Resources

$13.56

0.395 (3.00%)

WLL

Whiting Petroleum

$53.22

1.21 (2.33%)

HK

Halcon Resources

$5.49

-0.08 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 13

    Jun

  • 19

    Aug

PRA

ProAssurance

$40.10

0.15 (0.38%)

04:55
05/22/18
05/22
04:55
05/22/18
04:55
Conference/Events
ProAssurance management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 24

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.